Slideshow
Update on Stroke Risks
Author(s):
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
New neurology research indicates cirrhosis is linked to increased stroke risk, particularly hemorrhagic stroke, and that herpes zoster infection significantly raises the risks of stroke and MI. And the insomnia drug zolpidem may treat a variety of neurologic disorders.
Related Videos
Exploring Noninvasive Brain Stimulation for Neurorehabilitation: Roy H. Hamilton, MD, MS, FAAN
The Key Role of Early and Balanced Blood Pressure Control in ICH Management: Kara R. Melmed, MD
Aggressive Blood Pressure Lowering for Intracerebral Hemorrhage Management: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Nuances in Thrombectomy Techniques and Anesthesia Use for Stroke: J Mocco, MD, MS
Innovation in Stroke Care and Expanding the Treatment Windows: Keith Churchwell, MD, FAHA, FACC, FACP
Lessons Learned From the 2025 International Stroke Conference: Keith Churchwell, MD, FAHA, FACC, FACP
Key Considerations When Incorporating Stroke Trial Data Into Clinical Practice: J Mocco, MD, MS
Evaluating the Efficacy of Thrombectomy in Distal Vessel Occlusions: J Mocco, MD, MS
Evolution of Stroke Treatment on Display at ISC 2025: Andrei Alexandrov, MD
Expanding the Time Window for Intravenous Thrombolysis in Ischemic Stroke: Min Lou MD, PhD
Related Content
